NCT07226999 2026-04-08
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Pfizer
Phase 2/3 Recruiting
Clinical Trials
23 trialsNCT07476287 2026-04-08
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Pfizer
Phase 2 Recruiting
NCT07472647 2026-03-16
SYS6090 Combination Therapy in Advanced Lung Cancer
Shanghai JMT-Bio Inc.
Phase 1/2 Not yet recruiting
NCT06719700 2026-03-03
Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer
Sun Yat-sen University
Phase 2 Recruiting
NCT07358676 2026-01-22
A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT01064466 2025-07-24
Drugs-SNPs
Medicine Invention Design, Inc
Phase 2/3 Active not recruiting
NCT07076836 2025-07-22
Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
West China Hospital
Phase NA Not yet recruiting
NCT07069270 2025-07-16
A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT04952480 2025-06-12
DARTS
AHS Cancer Control Alberta
Phase 2 Recruiting
NCT05945745 2024-11-29
Molecular Analysis and Treatment Options of SCLC
Shanghai Chest Hospital
Recruiting
NCT06562920 2024-08-20
Neoadjuvant
Zhejiang Cancer Hospital
Phase 2 Recruiting
NCT04902885 2024-07-10
Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT06406660 2024-05-09
Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer
Henan Cancer Hospital
Phase NA Recruiting
NCT06223711 2024-04-05
Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC
Universität des Saarlandes
Phase 2 Recruiting
NCT06306560 2024-03-12
A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.
Harbin Medical University
Phase 2 Not yet recruiting
NCT05873790 2023-05-24
Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study
The First Hospital of Jilin University
Unknown
NCT04672759 2020-12-17
A Real-world Study of Durvalumab for Lung Cancer in China
Peking Union Medical College Hospital
Unknown
NCT03547804 2020-12-01
MK 01
The First Hospital of Jilin University
Phase 2 Completed
NCT00617409 2019-11-08
To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT03971214 2019-06-04
PICARES
ChineseAMS
Phase 1 Unknown
NCT03523234 2018-09-05
Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage
Shanghai Pulmonary Hospital, Shanghai, China
Phase NA Unknown
NCT02425072 2017-08-10
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
University of Kentucky
Phase 2 Withdrawn
NCT00403403 2011-04-29
A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)
Genentech, Inc.
Phase 2 Completed